Dr. Manish A. Shah

Dr. Manish A. Shah, MD, is a nationally distinguished medical oncologist renowned for his expertise in gastrointestinal cancers, particularly those of the stomach, esophagus, and colon. He serves as Director of the Gastrointestinal Oncology Program at Weill Cornell Medicine and NewYork-Presbyterian Hospital, where he also holds the title of Chief of the Solid Tumor Oncology Service. Dr. Shah earned his medical degree from Harvard Medical School and completed his residency in internal medicine at Duke University Medical Center, followed by fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. Board-certified in medical oncology and internal medicine, he is a leading authority in treating complex and rare GI malignancies.

Dr. Shah is deeply engaged in translational and clinical research, with a special focus on precision oncology and novel therapeutics. His work has led to the development of personalized treatment strategies based on tumor genetics and molecular profiling, helping to advance the field of targeted therapy in gastrointestinal cancers. He has led numerous clinical trials investigating new agents for upper GI cancers and has been instrumental in the approval of several novel treatments. A prolific researcher, Dr. Shah has authored or co-authored over 200 peer-reviewed publications in top-tier journals and remains active in shaping national and international cancer treatment guidelines.

Beyond his clinical and scientific achievements, Dr. Shah is a highly respected educator and mentor, guiding future oncologists through Weill Cornell’s fellowship and academic programs. He is an active member of professional organizations including the American Society of Clinical Oncology and the American Association for Cancer Research, where he contributes to ongoing initiatives in oncology education, innovation, and policy. Through his commitment to patient-centered care, academic excellence, and clinical advancement, Dr. Shah continues to make transformative contributions to the field of gastrointestinal oncology.